Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | FLT1 | P17948 | 1/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6059993 | 0.80 | POLB (0.58) | MEN1KMT2AMAPTNPSR1ALDH1A1 | |
| SCHEMBL28124049 | 0.76 | HDAC3 (0.53) | MEN1KMT2AMAPTNPSR1ALDH1A1 | |
| SCHEMBL14937993 | 0.74 | NPC1 (0.68) | MEN1KMT2AMAPTNPSR1ALDH1A1 | |
| SCHEMBL1828447 | 0.71 | F10 (0.52) | MEN1KMT2ARXFP1MAPTNPSR1 | |
| SCHEMBL13078556 | 0.70 | MEN1 (0.40) | MEN1KMT2ARXFP1MAPTALDH1A1 | |
| SCHEMBL1900620 | 0.70 | MAPK14 (0.59) | MEN1KMT2ARXFP1MAPTNPSR1 | |
| SCHEMBL14893308 | 0.69 | CYP3A4 (0.69) | MEN1KMT2ARXFP1MAPTALDH1A1 | |
| SCHEMBL19710265 | 0.68 | ALDH1A1 (0.65) | MAPTNPSR1ALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL13168267 | 0.68 | MEN1 (0.41) | MEN1KMT2ARXFP1MAPTALDH1A1 | |
| SCHEMBL7779037 | 0.68 | EPHX2 (0.61) | MEN1KMT2ARXFP1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070021509-A1 | Phosphate transport inhibitors | JOZEFIAK THOMAS H | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021509-A1 | Phosphate transport inhibitors | SLC34A2, SLC34A1, SLC20A1 | MEN1 2248/4885KMT2A 4634/4885RXFP1 949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.